New York Headache blog

by Dr. Alexander Mauskop
May 10, 2019
100 Migraine Drugs, A to Z: hydrocodone
May 10, 2019
Hydrocodone (Vicodin, Lortab, Norco) is an opioid or narcotic pain killer, which should not have much of a role to play in the treatment of migraine headaches. Opioids are much less effective for the treatment of migraines than...
Read article
May 4, 2019
Vitamin B12 deficiency, “A Problem That’s Easy to Miss”
May 4, 2019
The role of vitamin B12 is underappreciated by many doctors. This week, The Wall Street Journal published a full-page article on vitamin B12 deficiency, which can be of great help to many of the two million readers of this newspaper...
Read article
April 30, 2019
Men have migraines too
April 30, 2019
Migraine is rightfully considered a women’s health issue since of the more than 39 million Americans with migraines, 28 million are women. But 11 million is still a lot of men. Unfortunately, men do not seek help as often as...
Read article
April 27, 2019
100 Migraine drugs, A to Z: haloperidol
April 27, 2019
Haloperidol (Haldol) is a psychiatric drug prescribed for the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, nausea and vomiting, delirium, agitation, and acute psychosis. A cases series published...
Read article
April 21, 2019
100 MIgraine Drugs, A to Z: granisetron
April 21, 2019
Granisetron (Kytril, Sancuso) is one of the anti-nausea medications in the family of setrons. Ondansetron (Zofran) and palonosetron (Aloxi) are the other two drugs in this family available in the US. These drugs are approved...
Read article
April 17, 2019
The NY Headache Center is featured in this great new video
April 17, 2019
by Molly Rubin, a video journalist at Quartz. Quartz is a digital news site founded by the Atlantic. This is a very well done video news piece on migraines...
Read article
April 15, 2019
Migraine raises the risk of stroke if it begins after 50
April 15, 2019
Patients suffering from migraine with aura (MA) are at a higher risk of strokes. It is not clear what leads to this problem. Elevated homocysteine level increases the risk of strokes and heart attacks and patients with MA...
Read article
April 12, 2019
This is a cluster season, again
April 12, 2019
Cluster headaches derive their name from the fact that they occur daily for a period of one to several months. It is rarely noted that these cluster periods occur in many patients at the same time. We do not see any cluster patients for...
Read article
April 8, 2019
100 Migraine Drugs, A to Z: galcanezumab
April 8, 2019
Galcanezumab (Emgality) was the third drug in the family of CGRP monoclonal antibodies (mAbs) to become approved by the FDA for the prevention of migraines. It is more similar to fremanezumab (Ajovy) in its mechanism of action...
Read article
April 4, 2019
Your brain needs vitamin D – keep your level up
April 4, 2019
Yet another study shows that low vitamin D level predisposes to neurological problems. A report just published in a leading neurology journal, Neurology by British and American researchers shows that low levels of vitamin D are...
Read article
March 28, 2019
Ginger improves emergency room treatment of migraine
March 28, 2019
Ginger is not only a popular spice, but a truly remarkable medicinal plant. Ginger’s proven anti-inflammatory properties may be responsible for its beneficial effects in migraine patients. Ginger may be effective for the treatment...
Read article
March 25, 2019
100 Migraine Drugs, A to Z: gabapentin
March 25, 2019
Gabapentin (Neurontin) is a drug that was originally developed for the treatment of epilepsy but now it is used for a wide variety of conditions except for epilepsy. It is just not strong enough to control epileptic seizures. Gabapentin...
Read article
March 18, 2019
More about our new study of tDCS for the prevention of migraines
March 18, 2019
To be eligible for this study you have to live in NYC or its suburbs and cannot be currently receiving Botox or a CGRP monoclonal antibody, such as Aimovig, Ajovy or Emgality...
Read article
March 16, 2019
A new study of Cefaly to treat acute migraines
March 16, 2019
Cefaly is a transcutaneous electrical nerve stimulation (TENS) device designed to treat migraine headaches by stimulating supraorbital nerves. The device was cleared by the FDA in 2014 for both acute and preventive treatment...
Read article
March 9, 2019
Migraines and dry eyes
March 9, 2019
Several older reports have suggested an association between dry eye disease (DED) and migraine headaches. Researchers at the Univercity of North Carolina at Chapel Hill just published a large and convincing study confirming...
Read article
March 5, 2019
100 Migraine Drugs from A to Z: frovatriptan
March 5, 2019
Frovatriptan (Frova) is one of seven drugs in the family of triptans, drugs used to abort a migraine attack. The first drug to receive approval in 1992 was sumatriptan (Imitrex) in an injection form, followed by tablets and nasal spray...
Read article
February 27, 2019
Must read! A very important new study of magnesium
February 27, 2019
A study just published in Neurology by the MEGASTROKE project of the International Stroke Genetics Consortium found that “genetically higher serum magnesium concentrations are associated with a reduced risk of...
Read article
February 21, 2019
100 Migraine Drugs, A to Z: fremanezumab
February 21, 2019
Fremanezumab (Ajovy) is one of the three drugs in the family of CGRP monoclonal antibodies that have been approved for the prevention of migraine headaches. Fremanezumab was approved by the FDA last September...
Read article
February 11, 2019
More magnesium, fewer migraines
February 11, 2019
Having conducted and published research on magnesium and seeing dramatic improvement from magnesium in many of my patients, I try to write about magnesium at least once a year. Up to half of migraine sufferers are...
Read article
February 2, 2019
100 Migraine Drugs, A to Z: flurbiprofen
February 2, 2019
Flurbiprofen is just another nonsteroidal antiinflammatory drug (NSAID), which is reflected in the name of its branded version – Ansaid. All NSAIDs can relieve acute pain of migraine and some have been proven to prevent...
Read article
January 30, 2019
TOSYMRA, a new migraine product was just approved by the FDA
January 30, 2019
Tosymra is a product that uses a novel way to deliver sumatriptan through the nasal passages. Unlike other nasal formulations of sumatriptan, Tosymra uses proprietary technology, Intravail, which enhances the absorption...
Read article
January 27, 2019
100 Migraine Drugs, A to Z: fluvoxamine
January 27, 2019
Fluvoxamine (Luvox) is one of the drugs in the selective serotonin reuptake inhibitor (SSRI) class. Unlike other SSRIs, which are approved for the treatment of anxiety and depression, it is approved for the treatment of obsessive...
Read article
January 20, 2019
100 Migraine drugs, A to Z: flunarizine
January 20, 2019
Flunarizine (Sibelium) is a calcium channel blocker approved for the preventive treatment of migraines in most countries, except for the US and Japan. In many countries, flunarizine is considered to be a first-line drug for...
Read article
January 14, 2019
I decided to stop Ajovy too
January 14, 2019
I’ve given myself an injection of Ajovy in November and December with some improvement and without constipation which I had from Aimovig. However, Ajovy did not prevent all of my migraines, especially those caused...
Read article
January 9, 2019
100 Migraine Drugs, A to Z: fluoxetine
January 9, 2019
Antidepressants are widely used for the preventive treatment of migraine headaches. However, some types of antidepressants are better for this purpose than other. Fluoxetine (Prozac, Sarafem) was the first drug in the...
Read article
January 3, 2019
Red wine and headaches in the WSJ
January 3, 2019
Red wine is a common trigger for migraines, although we still don’t know the cause or why red wine is worse than white. I was just interviewed for this article in the WSJ along with my friend Mo Levin of the UCSF headache clinic...
Read article
January 1, 2019
100 Migraine Drugs, A to Z: estrogen
January 1, 2019
Estrogen can be an effective agent for the treatment of menstrual migraines. Many women report that their migraines tend to occur before or during their period and sometimes with ovulation. For some women menstruation...
Read article
December 26, 2018
100 Migraine Drugs, A to Z: erenumab
December 26, 2018
Erenumab (Aimovig) was the first drug in the family of monoclonal antibodies (mAbs) against calcitonin gene-related peptide (CGRP) approved for the prevention of migraine headaches. CGRP is a substance released during a migraine...
Read article
December 21, 2018
Migraine aura increases the risk of atrial fibrillation, which may lead to a stroke
December 21, 2018
A typical migraine aura consists of a visual disturbance (partial loss of vision, flickering lights, zigzags, etc) which lasts 15 to 60 minutes and precedes the headache. Auras can also occur without a headache. Auras occurs in 15 to 20%...
Read article